Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections

NCT00210899 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.

NCT NCT00210899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections
Lead sponsor
Basilea Pharmaceutica
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
October 31, 2006
Enrollment
828 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

skin diseases, bacterial, skin diseases, infectious, staphylococcal skin infections